Global Point of Care & Rapid Diagnostics Market Size study, by Product (COVID-19 test products, Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products), By platform (Lateral Flow Assays, Dipsticks, Microfluid

Global Point of Care & Rapid Diagnostics Market Size study, by Product (COVID-19 test products, Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products), By platform (Lateral Flow Assays, Dipsticks, Microfluidics Molecular Diagnostics, Immunoassays), by Mode of Purchase (OTC Products, Prescription-based Products), by End-User (Clinical Laboratories. Ambulatory Care Facilities and Physician Offices, Pharmacies, retail clinics, & E-commerce Platforms, Hospitals, Critical Care Centers, Urgent care centers, Home Care & Self Testing, Other End-Users) and Regional Forecasts 2022-2028

Global Point of care & Rapid Diagnostics Market is valued at approximately USD 38.89 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.80% over the forecast period 2022-2028. The point of care and rapid diagnostics utilized to get an immediate result in the investigation of various diseases such as heart diseases, cancer, diabetes, and others are defined as a point of care (POC) and rapid diagnostics market. The market is driven by key factors such as supportive government policies and high prevalence of infectious diseases. The rising prevalence of chronic and infectious illnesses such as heart disease, hepatitis, cancer, gastrointestinal, respiratory, and sexually transmitted diseases (STDs) is driving the global point of care and rapid diagnostics market. For instance, According to UNAIDS, 20.6 million persons in East and Southern Africa were living with HIV in 2018. In the Middle East and North Africa, 20,000 new HIV infections were reported in 2019. Moreover, in 2019, an estimated 5.8 million persons in Asia Pacific were infected with HIV, with India and China leading the way. In India, over 2.1 million persons were infected with HIV in 2019. Hence, high incidence of HIV has led to an increase in demand for point-of-care and rapid diagnostics. Also, growing investments and funding for product development and increasing provider awareness about novel technologies create lucrative opportunities in the upcoming years. However, stringent regulatory policies impede the growth of the market over the forecast period of 2022-2028.

The geographical regions considered for the global Point of Care & Rapid Diagnostics market analysis include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is leading the market growth followed by Europe. Factors supporting the growth are increase in the number of product approvals and rise in the prevalence of lifestyle diseases. However, Lain America is projected to be the fastest growing region owing to increasing healthcare expenditure, increase awareness about early detection of diseases.





Major market players included in this report are:
Abbott Laboratories
Siemens Healthineers AG
Quidel Corporation
F. Hoffman-La Roche Ltd.
Danaher Corporation
Becton, Dickinson and Company
Chembio Diagnostics
EKF Diagnostics
Trinity Biotech plc
Instrumentation Laboratory

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
COVID-19 test products
Glucose Monitoring Products
Cardiometabolic Monitoring Products
Infectious Disease Testing Products
By Platform:
Lateral Flow Assays
Dipsticks
Microfluidics
Molecular Diagnostics
Immunoassays
By Mode of Purchase:
Prescription-based Products
OTC Products
End-User:
Clinical Laboratories
Ambulatory Care Facilities and Physician Offices
Pharmacies, retail clinics, & E-commerce Platforms
Hospitals, Critical Care Centers, Urgent care centers
Home Care & Self Testing
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Point of Care & Rapid Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Abbott Laboratories
Siemens Healthineers AG
Quidel Corporation
F. Hoffman-La Roche Ltd.
Danaher Corporation
Becton, Dickinson and Company
Chembio Diagnostics
EKF Diagnostics
Trinity Biotech plc
Instrumentation Laboratory

Please note:The single user license is non-downloadable and non-printable. Global Site license will allow these actions. Show more